Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Prattichizzo

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Ebiomedicine|January 19, 2019
Ageing as a druggable process: Moving forwardFrancesco Prattichizzo
Diabetes Research and Clinical Practice|February 2, 2020
The beneficial effects (on cardio-renal system) of glucose-lowering agents with caloric-restriction mimetic properties are subtractive rather than additiveFrancesco Prattichizzo
Diabetes Care|December 22, 2022
Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448Antonio Ceriello, Francesco Prattichizzo
Lancet (London, England)|January 4, 2025
The legacy effect of hyperglycaemia in type 2 diabetesFrancesco Prattichizzo, Antonio Ceriello
Journal of Diabetes and Its Complications|April 26, 2021
Pharmacological management of COVID-19 in type 2 diabetesAntonio Ceriello, Francesco Prattichizzo
The Lancet. Diabetes & Endocrinology|February 19, 2021
Positioning newer drugs in the management of type 2 diabetesFrancesco Prattichizzo, Antonio Ceriello
Diabetes/Metabolism Research and Reviews|July 9, 2021
Is time ready for combination therapy at diagnosis of type 2 diabetes?Francesco Prattichizzo, Antonio Ceriello
Cardiovascular Diabetology|May 8, 2021
Variability of risk factors and diabetes complicationsAntonio Ceriello, Francesco Prattichizzo
The New England Journal of Medicine|May 8, 2024
Microplastics and Nanoplastics in Atheromas. ReplyRaffaele Marfella, Francesco Prattichizzo
European Heart Journal|December 19, 2025
Hygiene measures and persistent adherence to SGLT-2 inhibitors minimize risks and maximize cardiorenal protectionFrancesco Cosentino, Francesco Prattichizzo, Antonio Ceriello
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Ebiomedicine|January 19, 2019
Ageing as a druggable process: Moving forwardFrancesco Prattichizzo
Diabetes Research and Clinical Practice|February 2, 2020
The beneficial effects (on cardio-renal system) of glucose-lowering agents with caloric-restriction mimetic properties are subtractive rather than additiveFrancesco Prattichizzo
Diabetes Care|December 22, 2022
Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448Antonio Ceriello, Francesco Prattichizzo
Lancet (London, England)|January 4, 2025
The legacy effect of hyperglycaemia in type 2 diabetesFrancesco Prattichizzo, Antonio Ceriello
Journal of Diabetes and Its Complications|April 26, 2021
Pharmacological management of COVID-19 in type 2 diabetesAntonio Ceriello, Francesco Prattichizzo
The Lancet. Diabetes & Endocrinology|February 19, 2021
Positioning newer drugs in the management of type 2 diabetesFrancesco Prattichizzo, Antonio Ceriello
Diabetes/Metabolism Research and Reviews|July 9, 2021
Is time ready for combination therapy at diagnosis of type 2 diabetes?Francesco Prattichizzo, Antonio Ceriello
Cardiovascular Diabetology|May 8, 2021
Variability of risk factors and diabetes complicationsAntonio Ceriello, Francesco Prattichizzo
The New England Journal of Medicine|May 8, 2024
Microplastics and Nanoplastics in Atheromas. ReplyRaffaele Marfella, Francesco Prattichizzo
European Heart Journal|December 19, 2025
Hygiene measures and persistent adherence to SGLT-2 inhibitors minimize risks and maximize cardiorenal protectionFrancesco Cosentino, Francesco Prattichizzo, Antonio Ceriello
Pageof 13